Skip to main content

Table 1 Patient characteristics

From: Percutaneous versus thoracoscopic ablation of symptomatic paroxysmal atrial fibrillation: a randomised controlled trial - the FAST II study

 

CA

VATS PVI

Age at procedure – Years (Mean ± SD)

55.5 (8.1)

53.5 (6.7)

BMI (Mean ± SD)

27.8 (4.4)

28.1 (3.8)

LVEF % (Mean ± SD)

64.5 (4.7)

63.5 (7.1)

LA Diameter – mm (Mean ± SD)

42.2 (3.2)

42.3 (5.1)

DC-conversion pre proc. (Mean ± SD)

2.3 (3.0)

1.5 (3.2)

Sex (Male/Female)

8/3

9/1

Hypertension, n (%)

4 (36.4)

3 (30)

Symptoms - EHRA 2, n (%)

5 (45.5)

5 (50)

Symptoms - EHRA 3, n (%)

6 (54.5)

5 (50)

CHADS2 – score 0, n (%)

4 (36.4)

5 (50)

CHADS2 – score 1, n (%)

4 (36.4)

4 (40)

CHADS2 – score 2, n (%)

3 (27.2)

1 (10)

COPD, n (%)

0

0

Diabetes, n (%)

2 (18.2)

0 (0)

AAD - 0

0

1 (10)

AAD - 1

2 (18.2)

1 (10)

AAD - 2

6 (54.5)

3 (30)

AAD – 3

3 (27.3)

3 (30)

AAD - 4

0

0

AAD - 5

0

2 (20)